Physician

Victor M Priego, M.D.

According to 2025 Medicare claims, Victor Priego, M.D. (NPI: 1003875295) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 20817-1915.

Priego's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 811 traditional Medicare patients, billed 369,095 HCPCS/CPT codes, and received $5,620,553 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 834 prescription claims across 152 beneficiaries totaling $4,336,948 in drug costs, led by Revlimid (Lenalidomide). DME data shows 240 claims. Open Payments data shows 224 records totaling $541,187. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $886,479 to $4,336,948. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	789	441,611	$3,557,702
2016	910	632,475	$4,001,824
2017	890	512,720	$3,633,604
2018	794	514,662	$4,430,856
2019	692	583,779	$5,312,824
2020	720	427,957	$4,659,972
2021	800	414,880	$4,259,986
2022	885	457,442	$4,224,761
2023	893	391,860	$4,516,748
2024	811	369,095	$5,620,553

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	127	745	$886,479
2016	130	663	$954,268
2017	119	627	$1,666,631
2018	131	580	$1,577,682
2019	112	540	$1,463,520
2020	118	614	$2,446,637
2021	131	679	$2,966,654
2022	131	574	$3,306,519
2023	142	736	$4,358,977
2024	152	834	$4,336,948

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	79	$73,884
2017	N/R	N/R	N/R
2018	N/R	16	$5,059
2019	N/R	40	$50,180
2020	N/R	26	$29,065
2021	N/R	28	$63,670
2022	N/R	230	$146,195
2023	N/R	235	$174,133
2024	N/R	240	$179,144

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	390	733	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	550	1,374	$74
80053	Blood test, comprehensive group of blood chemicals	314	576	$10
36415	Insertion of needle into vein for collection of blood sample	603	2,158	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	608	2,262	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	39	1,071	$671,868
Jakafi	Ruxolitinib Phosphate	32	960	$549,896
Ibrance	Palbociclib	24	672	$360,127
Fotivda	Tivozanib Hcl	11	308	$316,819
Doptelet	Avatrombopag Maleate	11	370	$263,906

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4193	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix	N	N/R	54	$92,444
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	14	$60,245
B4224	Parenteral nutrition administration kit, per day	N	N/R	54	$10,075
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	52	$9,261
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	185	$4,897	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	39	$536,291	PharmaEssentia USA Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Victor M. Priego, M.D.?

Tedicare shows public-source Medicare data for Victor M. Priego, M.D. (NPI 1003875295), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Victor M. Priego, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Victor M. Priego, M.D.?

Victor M. Priego, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Victor M. Priego, M.D. have Open Payments data?

Victor M. Priego, M.D. has 224 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.